Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
CALL
Tyson Foods
TSN
$19.8B
| $62.6M | 0.02% |
727,800
+45,600
| +7% | +$4.09M |
|
827
PUT
Phillips 66
PSX
$92.8B
| $62.6M | 0.02% |
763,100
+119,100
| +18% | +$11M |
|
828
ASML
ASML
$710B
| $62.5M | 0.02% |
131,294
+92,037
| +234% | +$51.4M |
|
829
PUT
Beyond Meat
BYND
$210M
| $62.5M | 0.02% |
2,609,300
+384,500
| +17% | +$12.3M |
|
830
Marriott International
MAR
$91.9B
| $62.2M | 0.02% |
457,254
+329,392
| +258% | +$54.4M |
|
831
Clorox
CLX
$12.9B
| $62M | 0.02% |
439,582
+333,429
| +314% | +$47.6M |
|
832
CALL
Five Below
FIVE
$13.4B
| $62M | 0.02% |
546,300
-50,400
| -8% | -$7.25M |
|
|
BKI
833
DELISTED
Black Knight, Inc. Common Stock
BKI
| $62M | 0.02% |
947,641
+733,818
| +343% | +$49.4M |
|
834
CALL
Warner Bros
WBD
$69.6B
| $61.7M | 0.02% |
4,600,988
+3,741,588
| +435% | +$69.4M |
|
835
Johnson & Johnson
JNJ
$632B
| $61.6M | 0.02% |
346,806
-731,210
| -68% | -$130M |
|
836
Southwest Airlines
LUV
$22B
| $61.5M | 0.02% |
1,702,535
+414,252
| +32% | +$17.8M |
|
837
CALL
GSK
GSK
$101B
| $61.4M | 0.02% |
1,129,120
+839,840
| +290% | +$46.4M |
|
|
838
PUT
Five Below
FIVE
$13.4B
| $61.4M | 0.02% |
541,400
+216,600
| +67% | +$31.2M |
|
839
CALL
Realty Income
O
$59.6B
| $61M | 0.02% |
893,400
+486,500
| +120% | +$33.4M |
|
840
Sunrun
RUN
$2.37B
| $61M | 0.02% |
2,610,310
+1,123,574
| +76% | +$27M |
|
|
ARCH
841
CALL
DELISTED
Arch Resources, Inc.
ARCH
| $60.9M | 0.02% |
425,600
+73,500
| +21% | +$11.7M |
|
842
Ultragenyx Pharmaceutical
RARE
$2.6B
| $60.7M | 0.02% |
1,017,303
-297,729
| -23% | -$18.3M |
|
843
PUT
APA Corp
APA
$14B
| $60.4M | 0.02% |
1,730,200
+138,500
| +9% | +$5.89M |
|
844
Owens Corning
OC
$12.3B
| $60.2M | 0.02% |
809,867
+678,760
| +518% | +$59.9M |
|
845
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.85B
| $60.2M | 0.02% |
+869,658
| New | +$61.4M |
|
|
CVII
846
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $60.2M | 0.02% |
6,156,987
+1,768,846
| +40% | +$17.3M |
|
847
Invesco QQQ Trust
QQQ
$487B
| $60.1M | 0.02% |
214,339
-107,081
| -33% | -$33.2M |
|
|
VG
848
DELISTED
Vonage Holdings Corporation
VG
| $60.1M | 0.02% |
3,188,541
+1,569,477
| +97% | +$30M |
|
849
First Solar
FSLR
$24B
| $60.1M | 0.02% |
881,545
+86,254
| +11% | +$6.14M |
|
850
RTX Corp
RTX
$297B
| $60.1M | 0.02% |
624,825
+590,849
| +1,739% | +$56.8M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.